3.48
Schlusskurs vom Vortag:
$3.56
Offen:
$3.61
24-Stunden-Volumen:
640.28K
Relative Volume:
0.57
Marktkapitalisierung:
$254.91M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-95.90M
KGV:
-2.6364
EPS:
-1.32
Netto-Cashflow:
$-79.09M
1W Leistung:
+19.01%
1M Leistung:
+39.56%
6M Leistung:
-49.93%
1J Leistung:
-34.31%
Terns Pharmaceuticals Inc Stock (TERN) Company Profile
Firmenname
Terns Pharmaceuticals Inc
Sektor
Branche
Telefon
650-525-5535 EXT.101
Adresse
1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY
Vergleichen Sie TERN mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
TERN
Terns Pharmaceuticals Inc
|
3.48 | 254.91M | 0 | -95.90M | -79.09M | -1.32 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
502.27 | 126.96B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
610.12 | 65.06B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ARGX
Argen X Se Adr
|
650.98 | 37.54B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
260.44 | 32.56B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
256.76 | 26.40B | 3.81B | -644.79M | -669.77M | -6.24 |
Terns Pharmaceuticals Inc Stock (TERN) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-02-28 | Eingeleitet | William Blair | Mkt Perform |
2024-10-31 | Eingeleitet | Oppenheimer | Outperform |
2023-06-22 | Eingeleitet | Mizuho | Buy |
2023-06-07 | Eingeleitet | Jefferies | Buy |
2023-05-31 | Eingeleitet | ROTH MKM | Buy |
2023-05-08 | Eingeleitet | BMO Capital Markets | Outperform |
2023-02-14 | Eingeleitet | JMP Securities | Mkt Outperform |
2023-02-07 | Eingeleitet | UBS | Buy |
2022-09-12 | Eingeleitet | H.C. Wainwright | Neutral |
2021-09-14 | Fortgesetzt | Goldman | Buy |
2021-03-02 | Eingeleitet | Cowen | Outperform |
2021-03-02 | Eingeleitet | Goldman | Buy |
2021-03-02 | Eingeleitet | JP Morgan | Overweight |
Alle ansehen
Terns Pharmaceuticals Inc Aktie (TERN) Neueste Nachrichten
What is Terns Pharmaceuticals Inc (TERN) Stock Return on Shareholders’ Capital? - Sete News
Terns Pharmaceuticals Inc (TERN) deserves deeper analysis - uspostnews.com
Terns Pharmaceuticals to Participate in The Citizens Life Sciences Conference - The Manila Times
Terns Pharma Leaders to Reveal Latest Oncology and Obesity Drug Pipeline Updates at Major Conference - Stock Titan
An Analysis of Terns Pharmaceuticals Inc (TERN)’s Potential Price Growth - knoxdaily.com
Terns Pharmaceuticals Inc’s: Contrasting Stock Performances in a Volatile Market - investchronicle.com
Terns Pharmaceuticals Inc (NASDAQ: TERN) Stock Could Make A -543.09% Loss - Marketing Sentinel
Analyzing Ratios: Terns Pharmaceuticals Inc (TERN)’s Financial Story Unveiled - DWinneX
Market Resilience: Terns Pharmaceuticals Inc (TERN) Finishes Weak at 2.10, Down -9.87 - DWinneX
A Look at Terns Pharmaceuticals Inc (TERN) Shares in the Recent Past Indicates Growth - Sete News
TERN overperforms with a 2.86 increase in share price - uspostnews.com
Geode Capital Management LLC Has $8.40 Million Holdings in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
A company insider recently sold 952 shares of Terns Pharmaceuticals Inc [TERN]. Should You also Consider to Sale? - knoxdaily.com
An Analysis Of Terns Pharmaceuticals Inc (TERN) Stock - Marketing Sentinel
We're Not Very Worried About Terns Pharmaceuticals' (NASDAQ:TERN) Cash Burn Rate - Yahoo Finance
TERN’s Stock Market Puzzle: Piecing Together 2023’s Performance - investchronicle.com
Terns Pharmaceuticals (NASDAQ:TERN) Receives Market Outperform Rating from JMP Securities - Defense World
Terns Pharmaceuticals Reports Third Quarter 2024 Financial Results and Corporate Updates - ADVFN
Terns Pharmaceuticals Reports Second Quarter 2024 Financial Results and Corporate Updates - ADVFN
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Stock Position Raised by LPL Financial LLC - Defense World
Alliancebernstein L.P. Has $2.01 Million Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Vanguard Group Inc. Has $21.44 Million Stake in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Mizuho maintains Outperform on Terns Pharma, $14 target By Investing.com - Investing.com Canada
Obesity Drug Developers Rise on M&A Hopes After Pfizer Setback - Bloomberg.com
American Century Companies Inc. Purchases 28,330 Shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
All You Need to Know About Terns Pharmaceuticals (TERN) Rating Upgrade to Buy - MSN
TERN Shares Experience Decline in Value - knoxdaily.com
Norges Bank Acquires New Stake in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Down -39.83% in 4 Weeks, Here's Why Terns Pharmaceuticals (TERN) Looks Ripe for a Turnaround - Yahoo Finance
Such Is The Power Of Terns Pharmaceuticals Inc (NASDAQ: TERN) - stocksregister.com
Down -31.41% in 4 Weeks, Here's Why You Should You Buy the Dip in Terns Pharmaceuticals (TERN) - Yahoo Finance
Terns pharmaceuticals chief medical officer sells $2,365 in stock By Investing.com - Investing.com South Africa
Terns pharmaceuticals chief medical officer sells $2,365 in stock - Investing.com Australia
Terns Pharmaceuticals Reports Inducement Grant To New Employees Under Nasdaq Listing Rule 5635(C)(4) - MarketScreener
Terns Pharmaceuticals stock hits 52-week low at $2.5 By Investing.com - Investing.com South Africa
Terns Pharmaceuticals Reports Inducement Grant to New Employees Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times
Terns Pharmaceuticals stock hits 52-week low at $2.5 - Investing.com India
Terns Pharmaceuticals stock hits 52-week low at $4.16 - MSN
Insider Purchases Worth US$5.17m See Losses As Terns Pharmaceuticals Market Value Drops To US$255m - simplywall.st
HighTower Advisors LLC Invests $468,000 in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Charles Schwab Investment Management Inc. Raises Stake in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Receives $18.30 Average Price Target from Analysts - Defense World
Terns Pharmaceuticals Reports 2024 Progress and Outlook - TipRanks
Terns Pharmaceuticals stock hits 52-week low at $3.08 By Investing.com - Investing.com South Africa
Terns Pharmaceuticals stock hits 52-week low at $3.08 - Investing.com
Bank of New York Mellon Corp Raises Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Connor Clark & Lunn Investment Management Ltd. Boosts Stake in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Terns Pharmaceuticals (NASDAQ:TERN) Earns Market Perform Rating from William Blair - Defense World
Finanzdaten der Terns Pharmaceuticals Inc-Aktie (TERN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Terns Pharmaceuticals Inc-Aktie (TERN) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Jung Melita Sun | Chief Business Officer |
Nov 30 '24 |
Buy |
5.11 |
2,250 |
11,498 |
2,250 |
Burroughs Amy L. | Chief Executive Officer |
Nov 30 '24 |
Buy |
5.11 |
510 |
2,606 |
19,609 |
Kuriakose Emil | Chief Medical Officer |
Jan 02 '25 |
Sale |
5.71 |
4,481 |
25,607 |
54,269 |
Vignola Mark J. | Chief Financial Officer |
Jan 06 '25 |
Sale |
5.80 |
9,059 |
52,500 |
74,752 |
Vignola Mark J. | Chief Financial Officer |
Jan 02 '25 |
Sale |
5.72 |
8,129 |
46,524 |
83,811 |
Quigley Jill M. | Director |
Jan 06 '25 |
Sale |
5.79 |
8,760 |
50,758 |
0 |
Quigley Jill M. | Director |
Jan 02 '25 |
Sale |
5.72 |
6,240 |
35,702 |
8,760 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):